Genetics and Clinical Aspects of Hematologic Neoplasms and Hematopoietic Transplantation

Foran, JM; Sanz, GF; Watts, JM; Brunner, AM; Fossard, G; Della Porta, MG; Tsai, XCH; Garcia-Manero, G; Dimicoli-Salazar, S; Fletcher, L; Kim, YJ; Font, P; Alfonso-Piérola, A; Alonso-Dominguez, JM; Benton, C; Hong, J; Malcovati, L; Mazure, D; Lee, JH; Yeh, SP; Goursaud, L; Barcellini, W; Wu, E; Corzo, D; Kuida, K; Stone, RM.

Phase 1 first-in-human dose-expansion study of the oral SF3B1 modulator H3B-8800 in lower-risk myelodysplastic syndrome

LEUKEMIA RESEARCH. 2025; 156: No. of citations: 10 [doi:10.1016/j.leukres.2025.107735]

Cesaro, S; Verheggen, I; Tridello, G; Styczynski, J; Roeven, WHM; Hwang, A; Stamouli, M; Petrov, Y; Ben Abdeljelil, N; Mazilier, P; Zaidman, I; Tambaro, FP; Elias, S; Verna, M; Ricoma, JM; Karas, M; Corral, LL; Goussetis, E; Cerretti, R; Perruccio, K; Hornakova, M; Wölfl, M; Nordlander, A; Biffi, A; Spadea, M; Salinas, AS; Bramanti, S; Belendez, C; Skert, C; Gozdzik, J; Cuoghi, A; Mas, MH; Pennisi, M; de Becker, A; Richardson, D; Peric, Z; de la Camara, R; Averbuch, D.

A survey on the practices and the management of hemorrhagic cystitis in patients who undergo allogeneic hematopoietic stem cell transplantation, on behalf of the Infectious Diseases Working Party of EBMT

BONE MARROW TRANSPLANTATION. 2025; 60: 1480-1486 No. of citations: 1 [doi:10.1038/s41409-025-02703-1]

Capes, A; Mooyaart, JE; Blaise, D; Bramanti, S; Kwon, M; Mohty, M; Chevallier, P; Vydra, J; Reményi, P; Forcade, E; Corral, LL; Itälä-Remes, M; Bazarbachi, A; Derenzini, E; Hoogenboom, JD; Kuball, J; Battipaglia, G; Malard, F; Ruggeri, A.

Impact of the addition of antithymocyte globulin to post-transplantation cyclophosphamide in haploidentical transplantation with peripheral blood compared to post-transplantation cyclophosphamide alone: A retrospective study on behalf of the Cellular Therapy and Immunobiology Working Party of the European Society for Blood and Marrow Transplantation

BRITISH JOURNAL OF HAEMATOLOGY. 2025; 207: 1529-1537 No. of citations: 4 [doi:10.1111/bjh.70050]

Chorafa, E; Iosifidis, E; Oletto, A; Warris, A; Castagnola, E; Bruggemann, R; Groll, AH; Lehrnbecher, T; Antolin, LF; Mesini, A; Alkhaaldi, AA; Baquero-Artigao, F; Cetin, BS; Ebrahimi-Fakhari, D; Emonts, M; Esposito, S; Fainardi, V; Ghimenton-Walters, E; Gijón, M; Guerrero, AG; Grasa, CD; Kairiene, I; Kildonaviciute, K; Kourti, M; Manzanares, A; Mendoza-Palomar, N; Noni, M; Papakonstantinou, E; Paulus, S; Perwein, T; Rascon, J; Rincón-López, E; Soler-Palacin, P; Solopova, G; Spoulou, V; Strenger, V; Tedford, K; Tzika, C; Zsigmond, B; Roilides, E.

Antifungal Use in Immunocompromised Children in Europe: A 12-Week Multicenter Weekly Point Prevalence Survey (CALYPSO)

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY. 2025; 47(6): 222-230 No. of citations: 2 [doi:10.1097/MPH.0000000000003070]

Carpio, C; de la Cruz-Vicente, F; García-Sanz, R; Zeberio, I; Barrenetxea, C; Domingo-Domenech, E; Bastos, M; Martinez, AR; Gómez-Prieto, P; Rodriguez, A; Casanova, M; Cladera-Serra, A; Cespedes, JN; Martínez, C; Moreno-Velázquez, M; Garcia-Galea, E; Abrisqueta, P; Bosch, F.

A phase Ib/II trial combining brentuximab vedotin with cyclophosphamide, procarbazine, prednisone, etoposide and mitoxantrone (BrEPEM) for older patients with untreated classical Hodgkin lymphoma: A multicentre GELTAMO trial

BRITISH JOURNAL OF HAEMATOLOGY. 2025; 207: 1348-1356 No. of citations: 4 [doi:10.1111/bjh.70028]

Gomez-Llobell, M; Smith, CS; Gómez-Costas, D; Gómez-Centurión, I; Domínguez, JMG; Escudero-Vilaplana, V; Bullido, YF; Carbonell, D; Pion, M; Bailén, R; Gil-Perotin, S; Ginés, MLM; Revuelta-Herrero, JL; Fernández-Caldas, P; Fernández, VAP; Collado-Borrell, R; Bastos-Oreiro, M; Villanueva-Bueno, C; García-Sanz, R; Kwon, M.

ICANS risk model in CD19 CAR-T therapy: insights from serum and CSF cytokine profiling

BONE MARROW TRANSPLANTATION. 2025; 60: 1351-1360 No. of citations: 21 [doi:10.1038/s41409-025-02679-y]

Marin-Quílez, A; Sánchez-Fuentes, A; Zamora-Cánovas, A; Gómez-González, PL; Diaz-Ajenjo, L; Benito, R; Rodríguez-Alén, A; Sevivas, T; Murciano, T; Murillo, L; Butta, NV; Revilla, N; Campos, R; Escribano, P; Esteve, J; Fernández-Mosteirin, N; Ferrer-Marin, F; Hernández, L; Huerta-Aragonés, J; León, A; López-Duarte, M; López, E; Martín-Salces, M; Nomdedeu, M; Oña, R; Peláez-Pleguezuelos, I; Ramos, F; Sebastián, E; Serrano, C; Sierra-Aisa, C; Vidal-Laso, R; González-Porras, JR; Lozano, ML; Bastida, JM; Rivera, J.

Insights into the clinical, platelet and genetic landscape of inherited thrombocytopenia with malignancy risk

BRITISH JOURNAL OF HAEMATOLOGY. 2025; 207: 1565-1577 No. of citations: 7 [doi:10.1111/bjh.70001]

Monje Fuente S; Del Cañizo López A; Ordóñez Pereira J; García-Casillas MA; Pérez Egido L; Bada Bosch I; Bueno Romero J; Cerdá Berrocal J; De La Torre Macías M; Cela De Julián E; González San Segundo C; de Agustín Asensio JC.

Intraoperative radiotherapy in the local control of chest wall Ewing sarcoma.

Cirugia pediatrica : organo oficial de la Sociedad Espanola de Cirugia Pediatrica. 2025; 38(3): 100-105 [doi:10.54847/cp.2025.03.13]

Bento, L; Gutiérrez, A; Martinez, C; Verdet, MCO; Sorribes, M; Caballero, AC; Peña, M; Pérez, A; Jiménez-Ubieto, A; Medina, L; Bastos-Oreiro, M; Caldas-González, PF; Navarro, B; Salcedo, I; Abrisqueta, P; Español, I; Cornago, J; Martín-Moro, F; García, L; Gómez, P; Varela, MR; Puente, M; Zanabili, J; Zudaire, T; Zeberio, I; del Campo, R; González, L; González, P; Blázquez, C; Rovira, J; Sitges, M; Franch-Sarto, M; Cabero, A; Mussetti, A; Montoro, J; Sampol, A; Sureda, A; Caballero, D; García-Sancho, AM.

Autologous stem cell transplantation for relapsed/refractory large B-cell lymphoma: a multicenter GETH-TC/GELTAMO study

Blood Advances. 2025; 9(13): 3281-3292 No. of citations: 4 [doi:10.1182/bloodadvances.2024015415]

Pena-Burgos, EM; Duart, MA; Lotto, FA; Bravo-Arribas, C; Martínez-Payo, C; De León-Luis, JA; Suárez-González, J; Pozo-Kreilinger, JJ; Regojo-Zapata, RM.

Intrauterine-diagnosed fetal intracranial adamantinomatous craniopharyngioma: A case report with histopathological and molecular characterization

INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS. 2025; 172: 645-649 No. of citations: 1 [doi:10.1002/ijgo.70357]

Verdú-Bou, M; Baptista, MJ; Ribeiro, ML; Méndez-López, A; Profitós-Pelejà, N; Frontzek, F; Roué, G; Mate, JL; Pellicer, M; Abrisqueta, P; Castellví, J; Bastos-Oreiro, M; Menárguez, J; Alcoceba, M; González-Barca, E; Climent, F; Salar, A; Sancho, JM; Staiger, AM; Ott, G; Anagnostopoulos, I; Esteller, M; Lenz, G; Tapia, G; Navarro, JT.

The role of miR-150-5p/E2F3/survivin axis in the pathogenesis of plasmablastic lymphoma and its therapeutic potential

Blood Advances. 2025; 9(12): 2953-2967 No. of citations: 5 [doi:10.1182/bloodadvances.2025016180]

Kuter, DJ; Ghanima, W; Cooper, N; Liebman, HA; Zhang, L; Hu, Y; Miyakawa, Y; Homenda, W; Galindo, LEM; Basquiera, AL; Tan, CW; Saydam, G; Huetter-Kroenke, ML; Chai-Adisaksopha, C; Gomez-Almaguer, D; Tran, H; Shin, HJ; Junior, ADD; Lazar, Z; Izquierdo, CP; Kirgner, I; Lucchini, E; Kuzmina, G; Fillitz, M; Audia, S; Taparia, M; Cordoba, M; Diab, R; Yao, MJ; Gouia, I; Lee, MCL; Daak, A.

Safety and efficacy of rilzabrutinib vs placebo in adults with immune thrombocytopenia: the phase 3 LUNA3 study

BLOOD. 2025; 145(24): 2914-2926 No. of citations: 60 [doi:10.1182/blood.2024027336]

Bergas, A; de Egea, G; Albasanz-Puig, A; Machado, M; Vinñdo, B; Estévez-Prieto, A; Maluquer, C; Carro, I; Pérez-González, A; Regalado-Artamendi, I; Gómez-Centurión, IA; Laporte-Amargós, J; Sastre-Escolà, E; Badia-Tejero, AM; García, P; Larrosa, N; Muñoz, P; Berbel, D; Ardanuy, C; Carratala, J; Gudiol, C.

Effectiveness of the BioFire FilmArray for the rapid detection of bloodstream infection in haematological patients with febrile neutropenia (the ONFIRE study): study protocol of a prospective, multicentre observational study at three reference university hospitals in Spain

BMJ Open. 2025; 15(6): No. of citations: 3 [doi:10.1136/bmjopen-2025-101040]

Westin, J; Phillips, TJ; Mehta, A; Hoffmann, MS; Gonzalez-Barca, E; Thieblemont, C; Bastos-Oreiro, M; Greil, R; Giebel, S; Wei, MC; Wang, J; Bucher, R; Sit, J; Penuel, E; Purev, E; Yee, DL; Bergua-Burgues, JM.

Mosunetuzumab plus Pola-CHP compared with Pola-R-CHP in previously untreated DLBCL: final results from a phase 2 study

Blood Advances. 2025; 9(10): 2461-2472 No. of citations: 15 [doi:10.1182/bloodadvances.2024014907]

Montoro, J; Eikema, DJ; Piepenbroek, B; Tuffnell, J; Halahleh, K; Kulagin, A; Alahmari, A; Aksoy, BA; Remenyi, P; Itaela-Remes, M; Gulbas, Z; Mcdonald, A; Apte, S; Kwon, M; Rovira, M; Kharya, G; Potter, V; Gambella, M; Schroeder, T; Giammarco, S; Bazarbachi, A; Aljurf, M; Ho, ALY; Dalle, JH; Vydra, J; Sanz, J; Perez-Simon, JA; Colita, A; Collin, M; Tanase, A; Halkes, C; Kulasekararaj, A; Risitano, A; de Latour, RP.

Donor impact on allogeneic transplant outcomes with PTCy for severe aplastic anemia: a study of the SAAWP EBMT

BONE MARROW TRANSPLANTATION. 2025; 60(8): 1152-1159 No. of citations: 6 [doi:10.1038/s41409-025-02633-y]

Battipaglia, G; Labopin, M; Kulagin, A; Versluis, J; Choi, G; Meijer, E; Rovira, M; van Gorkom, G; Kwon, M; Koc, Y; Vydra, J; Chiusolo, P; Patel, A; Piemontese, S; Sanz, J; Ruggeri, A; Nagler, A; Ciceri, F; Mohty, M.

Addition of mycophenolate mofetil to a calcineurin inhibitor and post-transplant cyclophosphamide results in lower incidence of extensive chronic graft-versus-host disease in HLA-matched allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in complete remission: a matched-pair analysis on behalf of the Acute Leukemia Working Party of the EBMT

BONE MARROW TRANSPLANTATION. 2025; 60: 1146-1151 No. of citations: 1 [doi:10.1038/s41409-025-02610-5]

González-Gil, C; Lopes, T; Morgades, M; Fuster-Tormo, F; Montesinos, P; Medina, CR; Hermosin, L; González-Martínez, T; Queipo, MP; González-Campos, J; Martínez-Sánchez, P; Díaz-Beya, M; Coll, R; Maluquer, C; Zamora, L; Artola, T; Vall-Llovera, F; Tormo, M; Torrent, A; Martínez-Laperche, C; Gil-Cortés, C; Barba, P; Cervera, M; Ribera, J; Fernández-Delgado, M; Ayala, R; Cladera, A; Mateos, MC; Vidal, MJ; Feliu, J; Torres, A; Azaceta, G; Calasanz, MJ; Bigas, A; Esteller, M; Orfao, A; Ribera, JM; Genescà, E.

Genetic evolution and relapse-associated mutations in adult T-cell acute lymphoblastic leukemia patients treated in PETHEMA trials

HemaSphere. 2025; 9(5): No. of citations: 2 [doi:10.1002/hem3.70148]

Puyo, PV; Christou, S; Campisi, S; Rodriguez-Sánchez, MA; Reidel, S; Perez-Hoyo, S; Mota, M; Savvidou, I; Rekleiti, A; Salvo, A; Voi, V; Ferrero, GB; Mandrile, G; Gaglioti, CM; Cela, E; Ponce-Salas, B; Bardón-Cancho, EJ; Flevari, P; Voskaridou-Dimoula, E; Nur, E; Biemond, BJ; Delaporta, P; Beneitez-Pastor, D; Gimbert, AC; Spasiano, A; Besse-Hammer, T; Lafiatis, IG; Dedeken, L; Raso, S; Ruiz-Llobet, A; Bagnato, S; Labarque, V; Glenthoj, A; Ruffo, GB; Guerzoni, ME; Hafraoui, K; Pistoia, L; Rosso, R; Tagliaferri, L; Gonzalez-Urdiales, P; Benghiat, FS; de Montalembert, M; Teles, MJ; Vanderfaeillie, A; Bertoni, E; Cuzzubbo, D; Ferreira, T; Saunders, CJ; Stiakaki, E; van de Velde, AL; Diamantidis, MD; Kerkhoffs, JLH; Oliveira, MI; Quota, A; Russo, R; Van Damme, A; Marina, MA; Reggiori, ML; Rijneveld, AW; Gallego, AR; Colombatti, R; Iolascon, A; Taher, A; Gulbis, B; Roy, NBA; Mañú-Pereira, MD.

COVID-19 in patients affected by red blood cell disorders, results from the European registry ERN-EuroBloodNet

Orphanet Journal of Rare Diseases. 2025; 20(1): No. of citations: 2 [doi:10.1186/s13023-025-03683-7]